GlobeNewswire by notified

Kvika banki hf.: Financial Results for Q1 2024

Share

At a board meeting on 2 May 2024, the Board of Directors and the CEO approved the interim financial statements of the Kvika banki hf. (“Kvika” or “the bank”) group for the period 1 January to 31 March 2024.

In Kvika’s financial statements for the period the insurance subsidiary TM tryggingar hf. (“TM”) is classified as held for sale. As a result, and in accordance with international financial reporting standards, the Group reports income from its insurance operations in a single line in the consolidated income statement as profit after tax from discontinued operations. The comparative figures of operations from 2023 have been restated accordingly.

Highlights of the 3M 2024 Interim Financial Statements:

  • Pre-tax profit, excluding TM insurance, amounted to ISK 1,215 million in Q1 2024, compared to ISK 895 million in Q1 2023 and increases by 36% from previous year.
  • Post-tax profit of the group amounted to ISK 1,083 million in Q1 2024, compared to ISK 1,167 million in Q1 2023 and decreases by 7% from previous year.
  • Pre-tax return on tangible equity (RoTE) was 12.1%, compared to 13.1% in Q1 2023. Return on tangible equity of continuing operations was 15.5% in the first quarter of 2024.
  • Earnings per share for the period was ISK 0.23 in Q1 2024, compared to ISK 0.24 in Q1 2023.

Income from banking and asset management:

  • Net interest income amounted to ISK 2,326 million, compared to ISK 1,985 million in Q1 2023 and increased by 17% from previous year.
  • Net interest margin was 3.8% in Q1 2024.
  • Net fee and commission income amounted to ISK 1,633 million, compared to ISK 1,488 million in Q1 2023 and increased by 10% from previous year.
  • Other net operating income was ISK 110 million, compared to ISK 16 million in the same period in 2023.

Income from assets held for sale:

  • Post-tax profit of assets classified as held for sale, which consist of subsidiary TM insurance, is summarized in the income statement and amounted to ISK 96 million over the period, compared to ISK 428 million in the same period in 2023.
  • Combined ratio of insurance operations was 100.5%, compared to 99.8% in the first quarter of 2023.

Key balance sheet figures:

  • Deposits from customers were ISK 137 billion, compared to ISK 134 billion at year-end 2023 and increased by 2.5% in the period.
  • Loans to customers were ISK 146 billion, compared to ISK 136 billion at year-end 2023 and increased by 7%.
  • Total assets were ISK 351 billion, compared to ISK 335 billion at year-end 2023.
  • Total equity of the group was ISK 83 billion at the end of the period, compared to ISK 82 billion at year-end 2023.
  • The capital adequacy ratio (CAR) was 22.1%, compared to 22.6% at year-end 2023 and the solvency ratio of the financial conglomerate was 1.18 at the end of the period, as determined on the basis of the unaudited net earnings in the quarter. Kvika's capital ratio as calculated under the Financial Undertakings Act No. 161/2002 was 21.7%.
  • Total liquidity coverage ratio (LCR) of the group was 286%, compared to 247% in year-end 2023.
  • Total assets under management were ISK 474 billion, compared to ISK 470 billion at year-end 2023.

Ármann Þorvaldsson, CEO of Kvika:

“Kvika's banking operations performed well in the first quarter, and it is great to see a significant increase in profits from Q1 last year. Profit before taxes in the first quarter, excluding TM's results, amounted to ISK 1,215 million, compared to ISK 895 million in the same period in 2023 – an increase of 36%.

Almost all income segments grew year-on-year while at the same time costs were successfully contained. Despite persistent inflation and significant wage increases, we were successful in keeping costs almost unchanged from year to year. All the bank's business units performed well in the first quarter, and it is pleasing to see the turnaround in the bank's operations in the UK after a challenging environment the past two years.

Return on tangible equity of the bank´s operations amounted to 15.5%, which is below our long-term goal, but we are seeing evidence that we should close in on that goal in the coming quarters.

TM's insurance operations were in line with expectations and comparable to the first quarter of last year, but Q1 is generally the most difficult for the insurance companies. However, market conditions were unfavourable during the period, and the company's financial income was therefore considerably below expectations.

Profit before taxes, including TM insurance, amounted to ISK 1,345 million. Return on tangible equity before taxes was 12.1%.

Work on the completion of the confirmatory due diligence and the signing of an SPA with Landsbankinn for the sale of TM has progressed well, and the bank will keep the market informed as matters develop.”

Presentation for shareholders and market participants

A presentation for shareholders and market participants will be held Thursday, 2 May, at 16:15 in Kvika’s headquarters on the 9th floor at Katrínartún 2, 105 Reykjavík. The presentation will be conducted in Icelandic and a live stream can be accessed on the following website:
https://kvika.is/kynning-a-uppgjori-3m-2024/
Meeting participants will be able to send questions before or during the meeting via ir@kvika.is.

Attached is the investor presentation. Additionally, a recording with English subtitles will be made available on Kvika’s website.

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Indberetning af ledende medarbejderes transaktioner17.5.2024 11:10:00 CEST | pressemeddelelse

MEDDELELSE NR. 268 Indberetning af ledende medarbejderes transaktioner ChemoMetec A/S har i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget nedenstående indberetning om transaktioner i ChemoMetec A/S aktier udført af personer med ledelsesansvar og/eller personer, der er nært knyttet til dem. Se indberetning af bestyrelsesformand Niels Thestrups transaktioner i vedhæftede pdf-dokument. Yderligere oplysninger kan fås ved henvendelse til: Niels Høy Nielsen, CFO Telefon: (+45) 25 51 87 24 Om ChemoMetec A/S ChemoMetec udvikler, producerer og markedsfører instrumenter til celletælling og en lang række andre målinger. ChemoMetecs instrumenter markedsføres globalt inden for blandt andet farma, biotek og landbrug. ChemoMetec blev etableret i 1997 og er børsnoteret på Nasdaq Copenhagen. Se også www.chemometec.com Vedhæftet fil 2024-05-17 Niels Thestrup Indberetning

Notification of managers’ transactions17.5.2024 11:10:00 CEST | Press release

ANNOUNCEMENT NO. 268 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them. See the transactions of the Chair of ChemoMetec’s Board of Directors Niels Thestrup in the attached PDF document. For further information, please contact: Niels Høy Nielsen, CFO Telephone (+45) 2551 8724 About ChemoMetec A/S ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com. Attachment 2024-05-17 Niels Thestrup Notification

Establishment of a new subsidiary of the group17.5.2024 11:05:00 CEST | Press release

Establishment of a new subsidiary of the group AS Pro Kapital Grupp announces that a subsidiary company of the group, AS Pro Kapital Eesti, has established a new subsidiary, OÜ Pro Kapital Engineering. The new subsidiary will be active in residential and non-residential construction management. The share capital of OÜ Pro Kapital Engineering is EUR 2 500, which upon the establishment of the company belongs 100% to AS Pro Kapital Eesti. The members of the management board of the new company are Edoardo Axel Preatoni, the CEO of AS Pro Kapital Grupp and Andrus Laurits, the management board member of AS Pro Kapital Eesti. The establishment of the subsidiary does not have an effect of the economic activity of the issuer. AS Pro Kapital Grupp shall inform the investors through the Stock Exchange system additionally when further decisions have been made regarding the project. Edoardo Axel Preatoni Member of the Management Board Phone: +372 614 4920 e-mail: prokapital@prokapital.ee

Martela Plc - Managers' transactions – Kario17.5.2024 11:00:00 CEST | Press release

Martela Plc, Managers' transactions, 17.5.2024 at 12.00 ____________________________________________ Person subject to the notification requirement Name: Kario, Suvi-Maarit Position: Other senior manager Issuer: Martela Plc LEI: 743700M4EIEVD61PNN55 Notification type: INITIAL NOTIFICATION Reference number: 743700M4EIEVD61PNN55_20240516144935_59 ____________________________________________ Transaction date: 2024-05-16 Venue: XHEL Instrument type: SHARE ISIN: FI0009900385 Nature of the transaction: SUBSCRIPTION Transaction details (1): Volume: 1500 Unit price: 1.30 EUR Aggregated transactions (1): Volume: 1500 Volume weighted average price: 1.30 EUR Martela Plc Henri Berg CFO tel +358 40 8365 464 Distribution Nasdaq Helsinki Main news media www.martela.com Martela is a Nordic leader specialising in user-centric working and learning environments. We create the best places to work and offer our customers the Martela Lifecycle solutions which combine furniture and related services into a se

Copenhagen Infrastructure Partners, KK Invest and Danish Bio Commodities to operate and develop one of Denmark's largest biogas plants17.5.2024 11:00:00 CEST | Press release

KK Invest, DBC Invest and Copenhagen Infrastructure Partners have entered into an agreement regarding the acquisition of the majority of the shares in Sindal Biogas. The ambition is to build a flagship plant for bioenergy in Denmark and thereby contributing positively to the green transition in Hjørring Municipality and Denmark. COPENHAGEN, Denmark and HJØRRING, Denmark, May 17, 2024 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners (CIP) and the plant's current owners will invest in the ongoing expansion of the sustainable bioenergy sector in Hjørring in Northern Jutland, Denmark. The current owners include a local investment company with roots in agriculture, KK Invest (owned by the Glenthøj Kirketerp family), and DBC Invest (a sister company to Danish Bio Commodities). The purpose is to jointly develop, expand and operate the existing biogas plant as a continued hub for sustainable bioenergy in Northern Jutland. CIP's investment is made through its CI Advanced Bioenergy Fund I

HiddenA line styled icon from Orion Icon Library.Eye